Skip to content

Clinical trials

Active, not recruiting Phase 2 Carcinoma, Non-Small-Cell Lung trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Phase: Phase 2 Status: Active, not recruiting Clear all

146 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20131
20141
20152
20164
20178
201813
201913
202017
202121
202217
202326
202415
20256
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting146

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca11
National Cancer Institute (NCI)7
M.D. Anderson Cancer Center5
ETOP IBCSG Partners Foundation3
Fundación GECP3
Intergroupe Francophone de Cancerologie Thoracique3
Memorial Sloan Kettering Cancer Center3
Seagen, a wholly owned subsidiary of Pfizer3
Shanghai Pulmonary Hospital, Shanghai, China3
Sichuan Baili Pharmaceutical Co., Ltd.3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung146
Lung Neoplasms31
Melanoma8
Neoplasm Metastasis7
Neoplasms7
Brain Neoplasms6
Colorectal Neoplasms6
Carcinoma, Hepatocellular5
Carcinoma, Renal Cell5
Pancreatic Neoplasms5

Trials

Showing 1 to 25 of 146. Each trial links to its page on Pharma Observatory.

46 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.